Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis.

Guglielmetti L, Khan U, Velásquez GE, Gouillou M, Abubakirov A, Baudin E, Berikova E, Berry C, Bonnet M, Cellamare M, Chavan V, Cox V, Dakenova Z, de Jong BC, Ferlazzo G, Karabayev A, Kirakosyan O, Kiria N, Kunda M, Lachenal N, Lecca L, McIlleron H, Motta I, Toscano SM, Mushtaque H, Nahid P, Oyewusi L, Panda S, Patil S, Phillips PPJ, Ruiz J, Salahuddin N, Garavito ES, Seung KJ, Ticona E, Trippa L, Vasquez DEV, Wasserman S, Rich ML, Varaine F, Mitnick CD, endTB Clinical Trial Team

Open source

DOI: 10.1056/nejmoa2400327
Published: 2025 Jan 30
Container: The New England journal of medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2400327,
  title = {Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis.},
  author = {Guglielmetti L and Khan U and Velásquez GE and Gouillou M and Abubakirov A and Baudin E and Berikova E and Berry C and Bonnet M and Cellamare M and Chavan V and Cox V and Dakenova Z and de Jong BC and Ferlazzo G and Karabayev A and Kirakosyan O and Kiria N and Kunda M and Lachenal N and Lecca L and McIlleron H and Motta I and Toscano SM and Mushtaque H and Nahid P and Oyewusi L and Panda S and Patil S and Phillips PPJ and Ruiz J and Salahuddin N and Garavito ES and Seung KJ and Ticona E and Trippa L and Vasquez DEV and Wasserman S and Rich ML and Varaine F and Mitnick CD and endTB Clinical Trial Team},
  year = {2025},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa2400327},
  url = {https://doi.org/10.1056/nejmoa2400327}
}

RIS

TY  - JOUR
TI  - Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis.
AU  - Guglielmetti L
AU  - Khan U
AU  - Velásquez GE
AU  - Gouillou M
AU  - Abubakirov A
AU  - Baudin E
AU  - Berikova E
AU  - Berry C
AU  - Bonnet M
AU  - Cellamare M
AU  - Chavan V
AU  - Cox V
AU  - Dakenova Z
AU  - de Jong BC
AU  - Ferlazzo G
AU  - Karabayev A
AU  - Kirakosyan O
AU  - Kiria N
AU  - Kunda M
AU  - Lachenal N
AU  - Lecca L
AU  - McIlleron H
AU  - Motta I
AU  - Toscano SM
AU  - Mushtaque H
AU  - Nahid P
AU  - Oyewusi L
AU  - Panda S
AU  - Patil S
AU  - Phillips PPJ
AU  - Ruiz J
AU  - Salahuddin N
AU  - Garavito ES
AU  - Seung KJ
AU  - Ticona E
AU  - Trippa L
AU  - Vasquez DEV
AU  - Wasserman S
AU  - Rich ML
AU  - Varaine F
AU  - Mitnick CD
AU  - endTB Clinical Trial Team
PY  - 2025
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa2400327
UR  - https://doi.org/10.1056/nejmoa2400327
ER  -

APA

L, G., U, K., GE, V., M, G., A, A., E, B., E, B., C, B., M, B., M, C., V, C., V, C., Z, D., BC, D. J., G, F., A, K., O, K., N, K., M, K., N, L., L, L., H, M., I, M., SM, T., H, M., P, N., L, O., S, P., S, P., PPJ, P., J, R., N, S., ES, G., KJ, S., E, T., L, T., DEV, V., S, W., ML, R., F, V., CD, M., & Team, E. C. T. (2025). Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis.. The New England journal of medicine. https://doi.org/10.1056/nejmoa2400327

Source records

pubmed · retrieved 2026-09-27T13:04:49.923Z